Seegene Inc. Secures an Export Permit from South Korea's Ministry of Food and Drug Safety to Begin Exporting its COVID-19 Variant Tests to Countries Around the World
April 12, 2021 at 07:44 am EDT
Share
Seegene Inc. announced that it has secured an export permit from South Korea's Ministry of Food and Drug Safety to begin exporting its COVID-19 variant tests to countries around the world. The biotechnology firm said its supplying of the coronavirus variant diagnostic test will revamp the global efforts in countering the pandemic, coupled with more contagious and deadly virus variants.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
Seegene Inc. Secures an Export Permit from South Korea's Ministry of Food and Drug Safety to Begin Exporting its COVID-19 Variant Tests to Countries Around the World
SEEGENE, INC. 
